Baycol Injuries Class Action Lawsuit
Result: Confidential settlements
In re Baycol Products Litigation
Baycol was one of a group of drugs called statins, intended to reduce cholesterol. In August 2001, Bayer A.G. and Bayer Corporation, the manufacturers of Baycol, withdrew the drug from the worldwide market based upon reports that Baycol was associated with serious side effects and linked to the deaths of over 100 patients worldwide.
In the federal multi-district litigation, Lieff Cabraser served as a member of the Plaintiffs’ Steering Committee (PSC) and the Executive Committee of the PSC. In addition, Lieff Cabraser represented approximately 200 Baycol patients who suffered injuries or family members of patients who died allegedly as a result of ingesting Baycol. In these cases, our clients reached confidential favorable settlements with Bayer.
Civil Litigation News
Judge Will Grant Preliminary Approval to $255M Economic Loss Settlement Against Juul
As reported by Law360, on January 20, 2023, U.S. District Judge William H. Orrick of the Federal District Court for the Northern District
Consumer Class Action Over Evenflo Child Car Seats to Move Forward
On Wednesday, January 3, 2023, The 1st Circuit Court of Appeal in Boston declined to rehear its November 23rd decision reviving the
Federal Court says Evenflo must face ‘Big Kid’ booster seat safety litigation
The 1st Circuit Court of Appeal in Boston has revived class action litigation accusing Evenflo Company Inc of misleading consumers about the